ALISHA AMENDT: Open Payments
NPI 1114003027 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,779 in 66 payments from 12 companies in 2025. Trend: 2023 $1,166 · 2024 $1,277 · 2025 $1,779
Food & beverage: $1,779
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $599 |
| TG Therapeutics, Inc. | 2 | $275 |
| SK Life Science, Inc. | 5 | $242 |
| Ceribell, Inc. | 1 | $144 |
| Amgen Inc. | 1 | $131 |
| PFIZER INC. | 5 | $116 |
| ACADIA Pharmaceuticals Inc | 4 | $89 |
| Lundbeck LLC | 2 | $52 |
| Amneal Pharmaceuticals LLC | 2 | $43 |
| Merz Pharmaceuticals, LLC | 1 | $41 |
Products named: BRIUMVI, QULIPTA, BOTOX, POCKET EEG DEVICE, REPATHA, NURTEC ODT, NUPLAZID, VYALEV.
Industry payments across PA — which companies pay providers there.
